440 related articles for article (PubMed ID: 11973632)
1. Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide mu and plasmid DNA.
Tagawa T; Manvell M; Brown N; Keller M; Perouzel E; Murray KD; Harbottle RP; Tecle M; Booy F; Brahimi-Horn MC; Coutelle C; Lemoine NR; Alton EW; Miller AD
Gene Ther; 2002 May; 9(9):564-76. PubMed ID: 11973632
[TBL] [Abstract][Full Text] [Related]
2. Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems.
Keller M; Harbottle RP; Perouzel E; Colin M; Shah I; Rahim A; Vaysse L; Bergau A; Moritz S; Brahimi-Horn C; Coutelle C; Miller AD
Chembiochem; 2003 Apr; 4(4):286-98. PubMed ID: 12672108
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and formulation of neoglycolipids for the functionalization of liposomes and lipoplexes.
Perouzel E; Jorgensen MR; Keller M; Miller AD
Bioconjug Chem; 2003; 14(5):884-98. PubMed ID: 13129391
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core.
Murray KD; Etheridge CJ; Shah SI; Matthews DA; Russell W; Gurling HM; Miller AD
Gene Ther; 2001 Mar; 8(6):453-60. PubMed ID: 11313824
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity.
Saravolac EG; Ludkovski O; Skirrow R; Ossanlou M; Zhang YP; Giesbrecht C; Thompson J; Thomas S; Stark H; Cullis PR; Scherrer P
J Drug Target; 2000; 7(6):423-37. PubMed ID: 10758913
[TBL] [Abstract][Full Text] [Related]
6. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the interactions of adenovirus-derived peptides with plasmid DNA and their role in gene delivery mediated by liposome-peptide-DNA virus-like nanoparticles.
Preuss M; Tecle M; Shah I; Matthews DA; Miller AD
Org Biomol Chem; 2003 Jul; 1(14):2430-8. PubMed ID: 12956058
[TBL] [Abstract][Full Text] [Related]
8. Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties.
Zhang YP; Sekirov L; Saravolac EG; Wheeler JJ; Tardi P; Clow K; Leng E; Sun R; Cullis PR; Scherrer P
Gene Ther; 1999 Aug; 6(8):1438-47. PubMed ID: 10467368
[TBL] [Abstract][Full Text] [Related]
9. Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA.
Thierry AR; Rabinovich P; Peng B; Mahan LC; Bryant JL; Gallo RC
Gene Ther; 1997 Mar; 4(3):226-37. PubMed ID: 9135736
[TBL] [Abstract][Full Text] [Related]
10. A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes.
Tu Y; Kim JS
J Gene Med; 2008 Jun; 10(6):646-54. PubMed ID: 18383507
[TBL] [Abstract][Full Text] [Related]
11. A novel N-acyl phosphatidylethanolamine-containing delivery vehicle for spermine-condensed plasmid DNA.
Shangguan T; Cabral-Lilly D; Purandare U; Godin N; Ahl P; Janoff A; Meers P
Gene Ther; 2000 May; 7(9):769-83. PubMed ID: 10822304
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency.
Kim JK; Choi SH; Kim CO; Park JS; Ahn WS; Kim CK
J Pharm Pharmacol; 2003 Apr; 55(4):453-60. PubMed ID: 12803766
[TBL] [Abstract][Full Text] [Related]
13. Stabilized plasmid-lipid particles: construction and characterization.
Wheeler JJ; Palmer L; Ossanlou M; MacLachlan I; Graham RW; Zhang YP; Hope MJ; Scherrer P; Cullis PR
Gene Ther; 1999 Feb; 6(2):271-81. PubMed ID: 10435112
[TBL] [Abstract][Full Text] [Related]
14. Efficient topical delivery of plasmid DNA to lung in vivo mediated by putative triggered, PEGylated pDNA nanoparticles.
Aissaoui A; Chami M; Hussein M; Miller AD
J Control Release; 2011 Sep; 154(3):275-84. PubMed ID: 21699935
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
[TBL] [Abstract][Full Text] [Related]
16. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes.
Hwang SH; Hayashi K; Takayama K; Maitani Y
Gene Ther; 2001 Aug; 8(16):1276-80. PubMed ID: 11509962
[TBL] [Abstract][Full Text] [Related]
17. A hydroxyethylated cholesterol-based cationic lipid for DNA delivery: effect of conditioning.
Percot A; Briane D; Coudert R; Reynier P; Bouchemal N; Lièvre N; Hantz E; Salzmann JL; Cao A
Int J Pharm; 2004 Jun; 278(1):143-63. PubMed ID: 15158957
[TBL] [Abstract][Full Text] [Related]
18. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery.
Rajagopalan R; Xavier J; Rangaraj N; Rao NM; Gopal V
J Gene Med; 2007 Apr; 9(4):275-86. PubMed ID: 17397090
[TBL] [Abstract][Full Text] [Related]
19. S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA.
Trabulo S; Mano M; Faneca H; Cardoso AL; Duarte S; Henriques A; Paiva A; Gomes P; Simões S; de Lima MC
J Gene Med; 2008 Nov; 10(11):1210-22. PubMed ID: 18729238
[TBL] [Abstract][Full Text] [Related]
20. An electron microscopy study into the mechanism of gene transfer with lipopolyamines.
Labat-Moleur F; Steffan AM; Brisson C; Perron H; Feugeas O; Furstenberger P; Oberling F; Brambilla E; Behr JP
Gene Ther; 1996 Nov; 3(11):1010-7. PubMed ID: 9044741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
